Millennium Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.42M | Buy |
532,001
+294,327
| +124% | +$3.05M | ﹤0.01% | 3089 |
|
|
2025
Q4 | $2.94M | Buy |
237,674
+159,850
| +205% | +$1.71M | ﹤0.01% | 3580 |
|
|
2025
Q3 | $686K | Sell |
77,824
-677,608
| -90% | -$5.27M | ﹤0.01% | 4884 |
|
|
2025
Q2 | $4.82M | Sell |
755,432
-1,747,056
| -70% | -$10M | ﹤0.01% | 3040 |
|
|
2025
Q1 | $12.2M | Buy |
2,502,488
+1,020,582
| +69% | +$8.45M | 0.01% | 1981 |
|
|
2024
Q4 | $14.2M | Buy |
1,481,906
+671,947
| +83% | +$6.17M | 0.01% | 1828 |
|
|
2024
Q3 | $6.76M | Sell |
809,959
-136,343
| -14% | -$1.24M | ﹤0.01% | 2565 |
|
|
2024
Q2 | $6.45M | Buy |
946,302
+52,144
| +6% | +$224K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $2.26M | Sell |
894,158
-1,201,504
| -57% | -$2.71M | ﹤0.01% | 3621 |
|
|
2023
Q4 | $5.03M | Sell |
2,095,662
-1,570,717
| -43% | -$3.69M | ﹤0.01% | 2786 |
|
|
2023
Q3 | $12.5M | Buy |
3,666,379
+2,384,105
| +186% | +$13.2M | 0.01% | 1847 |
|
|
2023
Q2 | $9.42M | Buy |
1,282,274
+876,273
| +216% | +$8.13M | ﹤0.01% | 2078 |
|
|
2023
Q1 | $4.21M | Buy |
+406,001
| New | +$4.91M | ﹤0.01% | 2763 |
|
|
2022
Q4 | – | Sell |
-70,326
| Closed | -$1.48M | – | 6664 |
|
|
2022
Q3 | $1.48M | Sell |
70,326
-346,449
| -83% | -$9.64M | ﹤0.01% | 4013 |
|
|
2022
Q2 | $12.9M | Sell |
416,775
-75,861
| -15% | -$2.59M | 0.01% | 1737 |
|
|
2022
Q1 | $20.2M | Buy |
492,636
+92,268
| +23% | +$4.07M | 0.01% | 1386 |
|
|
2021
Q4 | $17.4M | Buy |
400,368
+392,709
| +5,127% | +$17.8M | 0.01% | 1568 |
|
|
2021
Q3 | $383K | Buy |
7,659
+814
| +12% | +$49.3K | ﹤0.01% | 5600 |
|
|
2021
Q2 | $431K | Buy |
6,845
+1,987
| +41% | +$128K | ﹤0.01% | 5428 |
|
|
2021
Q1 | $451K | Sell |
4,858
-44,116
| -90% | -$4.52M | ﹤0.01% | 4901 |
|
|
2020
Q4 | $4.39M | Sell |
48,974
-83,295
| -63% | -$7.64M | ﹤0.01% | 2567 |
|
|
2020
Q3 | $13.7K | Buy |
132,269
+127,333
| +2,580% | +$13.7M | 0.02% | 1025 |
|
|
2020
Q2 | $390K | Buy |
+4,936
| New | +$368K | ﹤0.01% | 3547 |
|
|
2020
Q1 | – | Sell |
-22,261
| Closed | -$1.2M | – | 3994 |
|
|
2019
Q4 | $1.2M | Sell |
22,261
-352,248
| -94% | -$19.1M | ﹤0.01% | 2917 |
|
|
2019
Q3 | $19.6M | Buy |
+374,509
| New | +$17.4M | 0.03% | 796 |
|
|
2018
Q3 | – | Sell |
-575,009
| Closed | -$29M | – | 3987 |
|
|
2018
Q2 | $29M | Sell |
575,009
-342,056
| -37% | -$17.8M | 0.04% | 664 |
|
|
2018
Q1 | $48.3M | Buy |
917,065
+209,581
| +30% | +$10.4M | 0.06% | 439 |
|
|
2017
Q4 | $32.9M | Buy |
707,484
+64,321
| +10% | +$2.71M | 0.05% | 605 |
|
|
2017
Q3 | $26M | Buy |
643,163
+125,603
| +24% | +$4.54M | 0.04% | 648 |
|
|
2017
Q2 | $17.6M | Sell |
517,560
-177,337
| -26% | -$5.47M | 0.03% | 739 |
|
|
2017
Q1 | $20.2M | Buy |
694,897
+548,780
| +376% | +$16.7M | 0.04% | 659 |
|
|
2016
Q4 | $4.8M | Buy |
+146,117
| New | +$4.38M | 0.01% | 1351 |
|
|
2016
Q3 | – | Sell |
-148,718
| Closed | -$4.18M | – | 3324 |
|
|
2016
Q2 | $4.18M | Sell |
148,718
-22,839
| -13% | -$895K | 0.01% | 1363 |
|
|
2016
Q1 | $6.24M | Buy |
171,557
+80,783
| +89% | +$2.85M | 0.02% | 1121 |
|
|
2015
Q4 | $3.63M | Buy |
90,774
+7,779
| +9% | +$271K | 0.01% | 1577 |
|
|
2015
Q3 | $2.37M | Buy |
+82,995
| New | +$2.73M | ﹤0.01% | 1797 |
|
|
2015
Q2 | – | Sell |
-210,500
| Closed | -$6.05M | – | 3436 |
|
|
2015
Q1 | $6.05M | Buy |
210,500
+190,857
| +972% | +$5.47M | 0.01% | 1305 |
|
|
2014
Q4 | $535K | Buy |
19,643
+3,943
| +25% | +$94K | ﹤0.01% | 2929 |
|
|
2014
Q3 | $335K | Buy |
15,700
+6,384
| +69% | +$146K | ﹤0.01% | 3005 |
|
|
2014
Q2 | $209K | Sell |
9,316
-106,285
| -92% | -$2.48M | ﹤0.01% | 3103 |
|
|
2014
Q1 | $2.92M | Buy |
115,601
+3,418
| +3% | +$86.3K | 0.01% | 1520 |
|
|
2013
Q4 | $2.58M | Sell |
112,183
-25,509
| -19% | -$532K | 0.01% | 1642 |
|
|
2013
Q3 | $2.62M | Sell |
137,692
-231,533
| -63% | -$4.13M | 0.01% | 1517 |
|
|
2013
Q2 | $5.32M | Buy |
+369,225
| New | +$5.35M | 0.02% | 983 |
|
Other funds holding EBS
VCM
PCM
VPM
Millennium Management's EBS Position: Q1 2026 in Review
Millennium Management increased its Emergent Biosolutions (EBS) stake by 124% in Q1 2026, buying an estimated $3.05M and bringing the position to 532,001 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3089.
Millennium Management first reported a position in EBS in Q2 2013 and has held it in 44 quarters since. The position peaked at $48.3M in Q1 2018. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Millennium Management held 532,001 shares of Emergent Biosolutions worth $4.42M as of Q1 2026.
- Millennium Management bought 294,327 Emergent Biosolutions shares in Q1 2026, an estimated $3.05M.
- Emergent Biosolutions made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3089 holding.
- Millennium Management first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 44 quarters since.
- Millennium Management's Emergent Biosolutions position peaked at $48.3M in Q1 2018.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.